The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

NCT03192644 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: TAI
PROCEDURE: TACE
DRUG: epidoxorubicin and cisplatin and lipiodol
DRUG: mFOLFOX6 (oxaliplatin, calcium folinate, and 5-FU)

Sponsor

Sun Yat-sen University